Health Status of Workers in Photocopier Units

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Avinashilingam Deemed University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
E. Nithya, Avinashilingam Deemed University
ClinicalTrials.gov Identifier:
NCT01267799
First received: December 28, 2010
Last updated: July 11, 2012
Last verified: July 2012
  Purpose

Photocopiers are indispensable in today's working environment. However, photocopiers emit a number of harmful chemicals during their operation. Photocopier toners also contain a number of potentially toxic substances. Chronic exposure to these substances may compromise the health of photocopier operators. This study is aimed to understand if chronic exposure to photocopier emissions is harmful to human health.


Condition
Exposure to Photocopiers on a Professional Basis

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Correlation Between Pulmonary Function and Selected Serum/Sputum Biomarkers of Pulmonary Damage Among Workers in Photocopier Units

Further study details as provided by Avinashilingam Deemed University:

Primary Outcome Measures:
  • To assess if photocopier emissions are toxic to human health [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • To assess the best biomarker for pulmonary damage in serum [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: July 2011
Groups/Cohorts
photocopier exposure

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

exposure to photocopier emissions

Criteria

Inclusion Criteria:

Exposure to photocopier emissions for minimum 2 years professionally

Exclusion Criteria:

Any clinical abnormality

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01267799

Contacts
Contact: Nithya Elango, M.Phil 091 98422 71110 nithya.s.chidambaram@gmail.com

Locations
India
Recruiting
Coimbatore, Tamilnadu, India, 641043
Avinashilingam Deemed University Recruiting
Coimbatore, Tamilnadu, India, 641043
Contact: Nithya Elango, M.Phil    091 98422 71110      
Principal Investigator: Nithya Elango, M.Sc., M.Phil         
Avinashilingam Deemed University for Women Not yet recruiting
Coimbatore, Tamilnadu, India, 641 043
Principal Investigator: Nithya Elango, M.Phil         
Sponsors and Collaborators
Avinashilingam Deemed University
Investigators
Study Director: Jeyanthi G P, Ph.D Avinashilingam Deemed University for Women
  More Information

No publications provided

Responsible Party: E. Nithya, Research Scholar, Avinashilingam Deemed University
ClinicalTrials.gov Identifier: NCT01267799     History of Changes
Other Study ID Numbers: photocopiers
Study First Received: December 28, 2010
Last Updated: July 11, 2012
Health Authority: India: Institutional Review Board

ClinicalTrials.gov processed this record on October 21, 2014